CANTEL INDUSTRIES INC
10-K/A, 1998-01-07
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: CANTEL INDUSTRIES INC, DEFR14A, 1998-01-07
Next: CHRIS CRAFT INDUSTRIES INC, 4, 1998-01-07



<PAGE>

                    SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                 Form 10-K/A-2

             Annual Report pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934
                  For the fiscal year ended July 31, 1997
                                           
                         Commission File No. 0-6132

                            CANTEL INDUSTRIES, INC.                    
       ----------------------------------------------------------------
           (Exact name of registrant as specified in its charter)

              DELAWARE                                   22-1760285      
- -----------------------------------              ------------------------
  (State or other jurisdiction of                (I.R.S. employer
   incorporation or organization)                identification no.)

        1135 BROAD STREET, CLIFTON, NEW JERSEY              07013   
- --------------------------------------------------------------------------
      (Address of principal executive offices)           (Zip code)

             Registrant's telephone number, including area code:
                               (201) 470-8700
                               --------------

    Securities registered pursuant to Section 12(b) of the Act: NONE 
                                                               -----
         Securities registered pursuant to Section 12(g) of the Act:
                   COMMON STOCK, PAR VALUE $.10 PER SHARE
                   --------------------------------------
                             (Title of Class)

Indicate by check mark whether registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to the filing
requirements for the past 90 days.  Yes  X    No    
                                        ---      ---

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K.   (X)

Aggregate market value of registrant's capital stock held by non-affiliates
(based on shares held and the closing price quoted by NASDAQ on October 8,
1997):    $14,674,436

Number of shares of common stock outstanding as of the close of the period
covered by this report: 4,166,322  

Documents incorporated by reference:  None

<PAGE>

                                       PART III


ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.

         The current directors and executive officers of the Company are as
follows:

NAME                    AGE             POSITION

Charles M. Diker        63        Chairman of the Board and Director
Alan J. Hirschfield     62        Vice Chairman of the Board, Director and a
                                  member of the Compensation Committee
James P. Reilly         57        President, Chief Executive Officer and
                                  Director
Darwin C. Dornbush      67        Secretary, Director and a member of both the
                                  Audit Committee and the Compensation
                                  Committee
Robert L. Barbanell     67        Director and a member of the Audit Committee
Richard L. Bloch        68        Director and a member of the Compensation
                                  Committee
Morris W. Offit         60        Director
Bruce Slovin            61        Director and a member of the Audit Committee  
Edward E. Meltz         64        Vice President
Craig A. Sheldon        35        Vice President and Controller


    Mr. Diker, who became Chairman of the Board of the Company in April 1986,
is a private investor and a non-managing principal of Weiss, Peck & Greer, an
investment management company.  Mr. Diker is also a director of BeautiControl
Cosmetics, Inc. (NASDAQ), a manufacturer of cosmetics marketed by direct sales,
International Specialty Products (NYSE), a specialty chemical company, Data
Broadcasting Corp. (NASDAQ), a communication services and technology company,
and Chyron Corporation (NYSE), a supplier of graphics for the television
industry.

    Mr. Hirschfield has served as Vice Chairman of the Board of the Company
since January 1988.  Since July 1992, he has served as Co-Chairman and Co-Chief
Executive Officer of Data Broadcasting Corp. (NASDAQ), a communication services
and technology company.  From October 1990 to July 1992, he served as Co-Chief
Executive Officer of FNN, Inc., the predecessor of Data Broadcasting Corp.  From
April 1990 to December 1992, he served 

                                         -2-
<PAGE>

as a managing director of Wertheim Schroder, Inc., an investment banking firm. 
Mr. Hirschfield is also a director of Chyron Corporation (NYSE), a supplier of
graphics for the television industry.

    Mr. Reilly has served as President and Chief Executive Officer of the
Company since June 1989.  Mr. Reilly is a certified public accountant.

    Mr. Dornbush, Secretary of the Company since July 1990, has been a partner
in the law firm of Dornbush Mensch Mandelstam & Schaeffer, LLP, which has been
general counsel to the Company for more than the past five years.  Mr. Dornbush
is also a director of Benihana, Inc. (NASDAQ), a company which operates Japanese
style restaurants.

    Mr. Barbanell has served as President of Robert L. Barbanell Associates,
Inc., a financial consulting company, since July 1994.  From September 1981 to
June 1994, Mr. Barbanell was employed in various capacities by Bankers Trust New
York Corporation, most recently as Managing Director of European Merchant Bank
of Bankers Trust International PLC.  Mr. Barbanell is also Chairman of the Board
and a director of Marine Drilling Companies, Inc. (NASDAQ), a drilling
contractor, a director of Kaye Group Inc. (NASDAQ), an insurance brokerage and
insurance underwriting company, and a director of Sentry Technology Corporation
(AMEX), a security products company.

    Mr. Bloch has served as President of Pinon Farm, Inc., a horse training and
breeding farm, since its inception in 1982.  From 1968 to October 1987, Mr.
Bloch served as President of the Phoenix Suns Basketball Club, a member of the
National Basketball Association.  Mr. Bloch was Chairman of the Board of
Governors of the National Basketball Association from 1985 to June 1987.  He is
a director of City National Bank of Beverly Hills, California (NYSE), a bank
holding company, and serves as Chairman of the Board of Columbus Realty Trust
(NYSE), a real estate investment trust.

    Mr. Offit has served as Chief Executive Officer of OFFITBANK, a limited
purpose trust company chartered by the New York State Banking Department, since
July 1990.  Prior thereto, Mr. Offit served as President of Offit Associates,
Inc., an investment counselling firm.  Mr. Offit is a Trustee of Johns Hopkins
University where he served as Chairman of the Board from 1990 through 1996, and
a former partner of Salomon Brothers, Inc.  He serves as a director of
Mercantile Bankshares Corp. (NASDAQ), a bank holding company, and Hasbro Inc.
(AMEX), a toy manufacturer.

                                         -3-
<PAGE>

    Mr. Slovin has served as President and a director of MacAndrews & Forbes
Holdings Inc. and Revlon Group, Inc., privately held industrial holding
companies, since 1985.  Mr. Slovin is also a director of Continental Health
Affiliates, Inc. (NASDAQ), a health care services company, The Coleman Company,
Inc. (NYSE), a manufacturer of outdoor recreation products, Meridian Sports
Incorporated (NASDAQ), a watersports company, Infu-Tech, Inc. (NASDAQ), a home
health care company, and M&F Worldwide Corp. (NYSE), a manufacturer of cigars
and licorice extract and flavorings.

    The following individuals are executive officers of subsidiaries who may be
deemed executive officers of the Company pursuant to Rule 3b-7 of the Securities
Exchange Act of 1934:

    Mr. William J. Vella (age 40) has been employed by Carsen Group Inc., a
wholly-owned subsidiary of the Company, in various capacities since October
1981.  He has served as Executive Vice President of Carsen since December 1994.

    Mr. Richard M. Rumble (age 39) has been employed by President and Chief
Executive Officer of MediVators, Inc., a wholly-owned subsidiary of the Company,
since August 1997.  For more than five years prior thereto, Mr. Rumble was
employed in various capacities by Minnesota Mining & Manufacturing Company,
Inc., most recently as Business Unit Manager of the Sterilization Assurance
Division.

                                         -4-
<PAGE>
 

ITEM 11. EXECUTIVE COMPENSATION.

    The following table sets forth, for the fiscal years ended July 31, 1997,
1996, and 1995, compensation, including salary, bonuses, stock options and
certain other compensation, paid by the Company to the Chief Executive Officer
and to the other executive officers of the Company who received more than
$100,000 in salary and bonus during fiscal year 1997:

<TABLE>
<CAPTION>

                                     SUMMARY COMPENSATION TABLE


                                                                                  LONG-TERM
                                                                                  COMPENSATION
                                              ANNUAL COMPENSATION (1)             AWARDS)(2)
                                              -----------------------             -----------

NAME AND                                             SALARY            BONUS         OPTIONS
PRINCIPAL POSITION                        YEAR        ($)               ($)             (#)
- --------------------------                ----       ------            -----          -----
<S>                                       <C>        <C>               <C>           <C>
Charles M. Diker                          1997       100,000             0            51,000
     Chairman of the Company              1996        83,333             0             1,000
                                          1995        75,000             0             1,000

James P. Reilly                           1997       250,000        12,600             1,000
     President and Chief Executive        1996       250,000             0             1,000
     Officer of the Company               1995       250,000             0             1,000

Edward E. Meltz (3)                       1997       149,230        12,200             3,000
     Vice President of the Company        1996       155,914             0             2,000
     and CEO and CFO of Carsen            1995       157,242             0             2,000

William J. Vella (3)                      1997       122,060        10,150             6,000
     President of Carsen                  1996       118,438         7,360            15,000
                                          1995       110,670             0             2,000

</TABLE>

______________________________

(1) The Company did not pay or provide other forms of annual compensation (such
    as perquisites and other personal benefits) to the above-named executive
    officers having a value exceeding the lesser of $50,000 or 10% of the total
    annual salary and bonus reported for such officers.

(2) The Company has no long-term incentive compensation plan other than its
    1991 Employee Stock Option Plan, the MediVators 1991 Stock Option Plan, and
    the 1991 Directors' Stock Option Plan described herein and various
    individually granted options. The Company does not award stock appreciation
    rights, restricted stock awards or long-term incentive plan pay-outs.

(3) Messrs. Meltz and Vella were paid their salary and bonus in Canadian 
    dollars. The dollar amounts above have been translated from Canadian 
    dollars to U.S. dollars based upon an average exchange rate during the 
    fiscal year.
 
                                           -5-
<PAGE>

STOCK OPTIONS

    The following information is furnished for the fiscal year ended July 31,
1997 with respect to the Company's Chief Executive Officer and the other
executive officers of the Company named in the Compensation Table above, for
stock options granted during such fiscal year.  Stock options were granted
without tandem stock appreciation rights.


<TABLE>
<CAPTION>

                                    OPTION GRANTS IN LAST FISCAL YEAR

                                     % OF TOTAL
                       NUMBER OF     OPTIONS                                            POTENTIAL REALIZABLE   
                       SHARES        GRANTED TO        EXERCISE                         VALUE AT ASSUMED ANNUAL
                       UNDERLYING    EMPLOYEES         PRICE                            RATES OF STOCK PRICE   
                       OPTIONS       DURING THE        PER            EXPIRATION        APPRECIATION FOR OPTION
NAME                   GRANTED       FISCAL YEAR       SHARE ($)      DATE              TERM ($) (1)           
- ----                   ----------    -----------       ---------      ----              ----------------------
                                                                                           5%           10%
                                                                                        -------      ---------

<S>                    <C>            <C>              <C>            <C>               <C>          <C>
Charles M. Diker       50,000 (2)       40.7           7.375          10/16/06          600,655      956,443
                        1,000 (3)        0.8           5.50           07/30/07            8,959       14,266

James P. Reilly         1,000 (3)        0.8           5.50           07/30/07            8,959       14,266

Edward E. Meltz         3,000 (4)        2.4           7.375          10/16/01           28,238       35,633

William J. Vella        6,000 (4)        4.9           7.375          10/16/01           56,475       71,265


</TABLE>
____________________________


(1) Represents the potential value of the options granted at assumed 5% and 10%
    rates of compounded annual stock price appreciation from the date of grant
    of such options.

(2) These options are non-plan options and vest in three equal annual 
    installments, the first on the date of grant. The exercise price per
    share of these options is the market value per share on the date of grant.

(3) The options were granted under the Company's 1991 Directors' Stock Option
    Plan.  The exercise price per share of the options was the market value per
    share on the date of grant.  The options are subject to vesting as follows:
    50%  of the total shares covered by the options vest on the first
    anniversary of the date of grant and the remaining 50% vest on the second
    anniversary of such date of grant.

                                           -6-
<PAGE>

(4) The options were granted under the Company's 1991 Employee Stock Option
    Plan.  The exercise price per share of the options was the market value per
    share on the date of  grant.  The options are subject to vesting as
    follows:  25% of the total shares covered by the options vest on each of
    the first four anniversaries of the date of the grant.

OPTION EXERCISE AND HOLDINGS

    The following information is furnished for the fiscal year ended July 31,
1997 with respect to the Company's Chief Executive Officer and the other
executive officers of the Company named in the Compensation Table above, for
stock option exercises during such fiscal year.


<TABLE>
<CAPTION>

                                    AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
                                            AND FISCAL YEAR-END OPTION VALUES

                     SHARES ACQUIRED    VALUE            NUMBER OF SHARES UNDERLYING         VALUE OF UNEXERCISED IN-THE-
NAME                 ON EXERCISE(#)     REALIZED($)     UNEXERCISED OPTIONS AT 7/31/97       MONEY OPTIONS AT 7/31/97 ($)
- ----------------     ---------------    ----------      -------------------------------    -------------------------------
                                                        EXERCISABLE     NON-EXERCISABLE    EXERCISABLE     NON-EXERCISABLE
                                                        -----------     ---------------    -----------     ---------------
<S>                      <C>              <C>           <C>                <C>               <C>             <C>
Charles M. Diker             0                 0            24,167           34,833            15,000               0
James P. Reilly              0                 0           194,315            1,500           711,556               0
Edward E. Meltz              0                 0             2,625            6,125             3,325           1,950
William J. Vella           5,000          18,750            11,000           19,500            10,469           2,656

</TABLE>


OPTION PLANS AND GRANTS

    An aggregate of 250,000 shares of Common Stock is reserved for issuance or
available for grant under the Company's 1991 Employee Stock Option Plan (the
"1991 Employee Plan").  Options granted under the 1991 Employee Plan are
intended to qualify as incentive stock options within the meaning of Section 422
of the Internal Revenue Code of 1986, as amended (the "Code").  The 1991
Employee Plan is administered in all respects by a committee composed of at
least two non-employee members of the Company's Board of Directors who are
designated by the Board (the "Stock Option Committee").  The Stock Option
Committee may determine the employees to whom options are to be granted and the
number of shares subject to each option.  Under the terms of the 1991 Employee
Plan, all employees of the Company or subsidiaries of the Company are eligible
for option grants.  The option exercise 

                                           -7-
<PAGE>

price of options granted under the 1991 Employee Plan is fixed by the Stock 
Option Committee but must be no less than 100% of the fair market value of 
the shares of Common Stock subject to the option at the time of grant, except 
that in the case of an employee who possesses more than 10% of the total 
combined voting power of all classes of stock of the Company (a "10% 
Holder"), the exercise price must be no less than 110% of said fair market 
value.  Options may be exercised by the payment in full in cash or by the 
tendering or cashless exchange of shares of Common Stock or of options to 
acquire shares of Common Stock having a fair market value, as determined by 
the Stock Option Committee, equal to the option exercise price.  Options 
granted under the 1991 Employee Plan may not be exercised more than ten years 
after the date of grant, five years in the case of an incentive stock option 
granted to a 10% Holder.  All options outstanding at July 31, 1997 have a 
term of five years. At July 31, 1997, options to purchase 139,750 shares of 
Common Stock at prices between $3.50 and $8.75 per share were outstanding
under the 1991 Employee Plan, and 70,625 shares were available for grant
under the 1991 Employee Plan.

    An aggregate of 200,000 shares of Common Stock is reserved for issuance or
available for grant under the Company's 1991 Directors' Stock Option Plan (the
"Directors' Plan").  Options granted under the Directors' Plan do not qualify as
incentive stock options within the meaning of Section 422 of the Code.  The
Directors' Plan provides for the automatic grant to each of the Company's
directors of options to purchase 1,000 shares of Common Stock on the last
business day of the Company's fiscal year.  In addition, an option to purchase
500 shares of Common Stock is granted automatically on the last business day of
each fiscal quarter to each director (exclusive of Messrs. Diker, Reilly and
Dornbush and any other director who serves as an officer or employee of the
Company) provided that the director attended any regularly scheduled meeting of
the Board, if any, held during such quarter.  Each such option grant is at an
exercise price equal to the fair market value of the Common Stock on the date of
grant and has a ten year term (but in no event more than three months following
the optionee's ceasing to serve as a director of the Company).  The fiscal year
options are exercisable in two equal annual installments commencing on the first
anniversary of the grant thereof and the quarterly options are exercisable in
full immediately.  At July 31, 1997, options to purchase 126,000 shares of
Common Stock at prices between $2.00 and $10.25 per share were outstanding under
the Directors' Plan, and 24,000 shares were available for grant under the
Directors' Plan.

    An aggregate of 200,000 shares of Common Stock is reserved for issuance or
available for grant under the Company's 1997 Employee Stock Option Plan approved
by the Company's Board of 

                                           -8-
<PAGE>

Directors on October 16, 1997 (the "1997 Employee Plan").  Options granted 
under the 1997 Employee Plan are intended to qualify as incentive stock 
options ("ISOs") within the meaning of Section 422 of the Code.  The 1997 
Employee Plan is administered in all respects by the Stock Option Committee.  
The Stock Option Committee may determine the employees to whom options are to 
be granted and the number of shares subject to each option.  Under the terms 
of the 1997 Employee Plan, all employees of the Company or subsidiaries of 
the Company are eligible for option grants.  The option exercise price of 
options granted under the 1997 Employee Plan is fixed by the Stock Option 
Committee but must be no less than 100% of the fair market value of the 
shares of Common Stock subject to the option at the time of grant, except 
that in the case of a 10% Holder, the exercise price for incentive stock 
options must be no less than 110% of said fair market value.  Options may be 
exercised by the payment in full in cash or by tendering shares of Common 
Stock having a fair market value, as determined by the Stock Option 
Committee, equal to the option exercise price.  Options granted under the 
1997 Employee Plan may not be exercised more than ten years after the date of 
grant, five years in the case of an incentive stock option granted to a 10% 
Holder.  To date, no options have been granted under the 1997 Employee Plan. 
The 1997 Employee Plan has been adopted by the Board of Directors and is 
subject to shareholder approval.

    The Company also has outstanding options granted by MediVators prior to the
Merger under the MediVators 1991 Stock Option Plan (the "MediVators Plan") which
became fully exercisable as a result of the Merger.  At July 31, 1997, options
to purchase 61,131 shares of Common Stock at prices between $6.08 and $8.27 per
share were outstanding under the MediVators Plan.  No future options will be
granted under the MediVators Plan. 

    In June 1990, Mr. Reilly was granted a ten-year non-plan option to purchase
139,815 shares of Common Stock at an exercise price of $1.75 per share.  This
option is exercisable in full.  In addition, in July 1990, Mr. Reilly was
granted a ten-year non-plan option to purchase 50,000 shares at an exercise
price of $1.875 per share.  This option is exercisable in full.

    In December 1994, Mr. Barbanell was granted a five-year non-plan option to
purchase 25,000 shares of Common Stock at an exercise price of $3.75 per share. 
This option is currently exercisable in full and expires in December 1999.

    In October 1996, Mr. Diker was granted a ten-year non-plan option to
purchase 50,000 shares of Common Stock at an exercise price of $7.375 per share.
This option is exercisable in three equal annual installments beginning October
1996.  In addition, in October 1997, Mr. Diker was granted a ten-year non-plan
option to purchase 50,000 shares of Common Stock at an exercise price of $7.00
per share.  This option is exercisable in three 

                                           -9-
<PAGE>

equal annual installments beginning October 1997.

DIRECTOR COMPENSATION

    Directors who are not officers of the Company were paid directors' fees of
$500 per meeting attended, plus expenses.  Under the 1991 Directors' Stock
Option Plan, directors who are not officers of the Company are automatically
granted quarterly options to purchase 500 shares of Common Stock, provided that
the director attended any regularly scheduled meeting of the Board, if any, held
during such fiscal year quarter.  Mr. Dornbush, who is both an officer and
director of the Company (and who thereby does not receive said quarterly option
grant) is granted a non-plan option to purchase 500 shares of Common Stock for
each such meeting attended by Mr. Dornbush.  In addition, under the 1991
Directors' Stock Option Plan, all directors are automatically granted annual
options to purchase 1,000 shares of Common Stock at the fiscal year end.

COMPENSATION COMMITTEE INTERLOCKS
AND INSIDER PARTICIPATION

    No officer of the Company served on the Company's compensation committee
during its last fiscal year. James P. Reilly, the President and Chief Executive
Officer of the Company, however, participated in deliberations concerning
executive compensation, except with respect to the compensation of the 
Chairman of the Board and himself.


Item 12. SECURITY OWNERSHIP OF BENEFICIAL OWNERS AND MANAGEMENT. 

    The following table sets forth stock ownership information as of October 8,
1997 concerning (i) each director and persons nominated to become directors of
Cantel, (ii) each person (including any "group" as defined in Section 13(d)(3)
of the Securities Exchange Act of 1934) who is known by Cantel to beneficially
own more than five (5%) percent of the outstanding shares of Cantel's Common
Stock, (iii) the Chief Executive Officer and the other executive officers named
in the Summary Compensation Table below, and (iv) Cantel's executive officers
and directors as a group:

                                          -10-
<PAGE>

<TABLE>
<CAPTION>


NAME AND ADDRESS OF                                AMOUNT AND NATURE
BENEFICIAL                  POSITION WITH          OF BENEFICIAL      PERCENTAGE OF
OWNERS                      COMPANY                OWNERSHIP (1)      CLASS
- ---------------------       -------------          -------------      -------------

<S>                        <C>                     <C>                <C>                                                      
Charles M. Diker            Chairman of the        799,667  (2)       19.0
One New York Plaza          Board and
New York, New York          Director

Alan J. Hirschfield         Vice Chairman of       219,333  (3)        5.2
P.O. Box 7443               the Board and
Jackson, Wyoming            Director

Richard L. Bloch            Director               363,500  (4)        8.7
16003 Via de Santa 
Fe
Rancho Santa Fe, 
California

James P. Reilly             President (CEO)        220,648  (5)        5.1
1135 Broad Street           and Director
Clifton, New Jersey

Bruce Slovin                Director               157,500  (6)        3.8

Morris W. Offit             Director                52,000  (7)        1.2

Darwin C. Dornbush          Secretary and           18,180  (8)         .4
                            Director

Robert L. Barbanell         Director                59,000  (9)        1.4

Edward E. Meltz             Vice President          45,070 (10)        1.1
                            of the Company
                            and CEO and CFO
                            of Carsen Group 
                            Inc.

William J. Vella            President and COO       30,135 (11)         .7
                            of Carsen Group
                            Inc.

All officers and directors                       1,980,033 (12)       43.4
as a group of 11 persons



</TABLE>

__________________________________


(1) Unless otherwise noted, Cantel believes that all persons named in the table
    have sole voting and investment power with respect to all shares of Common
    Stock beneficially owned by them.

                                          -11-
<PAGE>

    A person is deemed to be the beneficial owner of securities that can be
    acquired by such person within 60 days from October 8, 1997 upon the
    exercise of options.  Each beneficial owner's percentage ownership is
    determined by assuming that options that are held by such person (but not
    those held by any other person) and which are exercisable within 60 days
    from October 8, 1997 have been exercised.

(2) Includes 40,834 shares which Mr. Diker may acquire pursuant to stock
    options.  Does not include an aggregate of 478,715 shares owned by (i) Mr.
    Diker's wife, (ii) certain trusts for the benefit of Mr. Diker's children,
    (iii) certain accounts with Weiss, Peck and Greer, an investment firm of
    which Mr. Diker is a non-managing principal, over which accounts Mr. Diker
    exercises investment discretion, (iv) the DicoGroup, Inc., a corporation of
    which Mr. Diker serves as Chairman of the Board, and (v) a non-profit
    corporation of which Mr. Diker and his wife are the principal officers and
    directors.  Mr. Diker disclaims beneficial ownership as to all of the
    foregoing shares.

(3) Includes 23,000 shares which Mr. Hirschfield may acquire pursuant to stock
    options.

(4) Includes 20,000 shares which Mr. Bloch may acquire pursuant to stock
    options.

(5) Includes 194,315 shares which Mr. Reilly may acquire pursuant to stock
    options.

(6) Includes 22,500 shares which Mr. Slovin may acquire pursuant to stock
    options.  Does not include an aggregate of 9,000 shares owned by (i)
    certain trusts for the benefit of Mr. Slovin's children and (ii) a
    charitable foundation established by Mr. Slovin.  Mr Slovin disclaims
    beneficial ownership as to all of the foregoing shares.

(7) Includes 20,000 shares which Mr. Offit may acquire pursuant to stock
    options.

(8) Includes 9,500 shares which Mr. Dornbush may acquire pursuant to stock
    options.

(9) Includes 34,000 shares which Mr. Barbanell may acquire pursuant to stock
    options.  Does not include 2,500 shares owned by Mr. Barbanell's wife as to
    which Mr. Barbanell disclaims beneficial ownership.

(10)Includes 4,375 shares which Mr. Meltz may acquire pursuant to stock
    options.

                                          -12-
<PAGE>

(11)     Includes 16,750 shares which Mr. Vella may acquire pursuant to stock
         options.

(12)     Includes 400,274 shares which may be acquired pursuant to stock 
         options.




                                          -13-
<PAGE>

                                      SIGNATURES



    Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.


Date:  January 7, 1998



                              CANTEL INDUSTRIES, INC.
                              
                              
                              
                              By: /s/ James P. Reilly         
                                  -----------------------------
                                  James P. Reilly, President
                                  and Chief Executive Officer
                                  (Principal Executive Officer
                                  and Principal Financial
                                  Officer)
                              
                              
                              By: /s/ Craig A. Sheldon        
                                  ----------------------------
                                  Craig A. Sheldon, Vice
                                  President and Controller
                                  (Chief Accounting Officer)    
                              

                                         -14-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission